Clinuvel Pharmaceuticals (ADR) (CUVL)
Commercializes SCENESSE® for adult EPP and develops melanocortin therapies.
$5.84
vs last close+0.04 (+0.65%)
Something off on this page? Send us feedback.
Dividend yield
0.62%
Next ex-date
Sep 8, 27
estimated · in 351 days
Annual dividend
$0.04
per share
Schedule
Annual
one payment a year
Per share, Sep 2022 to Sep 2026DividendAnnual yield
———Sep '22Sep '23Sep '24Sep '25Sep '26
Dividend———$0.027$0.032$0.034$0.0264$0.036
Annual yield———————0.60%
Ex-date———Sep 9Sep 7Sep 9Sep 8Sep 8
Payment date———Oct 3Oct 2Sep 30Sep 29Sep 28
5 payments since Sep 2022
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Sep 8, 2026 | Sep 8, 2026 | Sep 28, 2026 | $0.036 | raised from $0.0264 |
| Sep 8, 2025 | Sep 8, 2025 | Sep 29, 2025 | $0.0264 | cut from $0.034 |
| Sep 9, 2024 | Sep 9, 2024 | Sep 30, 2024 | $0.034 | raised from $0.032 |
| Sep 7, 2023 | Sep 8, 2023 | Oct 2, 2023 | $0.032 | raised from $0.027 |
| Sep 9, 2022 | Sep 12, 2022 | Oct 3, 2022 | $0.027 |